Sab Biotherapeutics, Inc. [SABS]

Source: 

Company Overview

Sab Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of proprietary immunotherapeutic fully-human antibodies, or fully-human immunoglobulins, to treat and prevent immune and autoimmune disorders as well as infectious diseases that have significant mortality and health impacts on high-risk patients.